Tong Shen Selected Research

Tong Shen Research Topics

Disease

35	Neoplasms (Cancer) 12/2023 - 11/2007
14	Inflammation (Inflammations) 01/2023 - 01/2017
12	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 05/2015
8	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2015
8	Dermatitis 01/2020 - 10/2007
7	Wounds and Injuries (Trauma) 11/2020 - 12/2012
6	Colitis 01/2022 - 02/2018
6	Hypersensitivity (Allergy) 11/2020 - 09/2008
5	Obesity 01/2023 - 11/2018
4	Body Weight (Weight, Body) 01/2023 - 01/2017
3	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2007
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2023 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2023 - 01/2019
3	Carcinogenesis 01/2023 - 05/2015
3	Pneumonia (Pneumonitis) 09/2022 - 08/2018
3	Pain (Aches) 01/2020 - 12/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 11/2016
3	Necrosis 10/2019 - 08/2014
2	Vascular Remodeling 02/2024 - 01/2017
2	Ischemic Stroke 02/2024 - 01/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 09/2008
2	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 03/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 02/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2021
2	Insulin Resistance 01/2023 - 01/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 07/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2013
2	Immune System Diseases (Immune Disorders) 10/2020 - 10/2016
2	Lung Injury 08/2018 - 05/2018
2	Pathologic Processes 08/2017 - 01/2017
2	Stroke (Strokes) 01/2017 - 01/2017
2	Edema (Dropsy) 09/2015 - 07/2010
2	Erythema 09/2015 - 07/2010
1	Hypertension (High Blood Pressure) 03/2024
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Mesothelioma 01/2023

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2007
13	Trichloroethylene (Trichloroethene)IBA 11/2020 - 10/2007
9	CytokinesIBA 02/2023 - 09/2015
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2015
8	bisphenol AIBA 10/2023 - 10/2016
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
5	ErbB Receptors (EGF Receptor)IBA 01/2017 - 11/2007
4	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2017
4	EnzymesIBA 01/2023 - 01/2016
4	Adenosine Triphosphate (ATP)IBA 01/2023 - 11/2007
4	CollagenIBA 09/2022 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2022
3	MicroRNAs (MicroRNA)IBA 01/2023 - 08/2017
3	AzoxymethaneIBA 01/2021 - 05/2015
3	SolventsIBA 01/2020 - 11/2018
3	Suramin (Suramin Sodium)IBA 07/2012 - 09/2008
3	Tyrosine Kinase InhibitorsIBA 01/2010 - 11/2007
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2009 - 11/2007
2	Carbon Nanotubes (Carbon Nanotube)IBA 02/2023 - 09/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 08/2017
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
2	Glycerophospholipids (Phosphoglycerides)IBA 01/2023 - 01/2022
2	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 10/2009
2	NickelIBA 01/2023 - 06/2020
2	LipidsIBA 07/2022 - 10/2019
2	atezolizumabIBA 03/2022 - 11/2021
2	Protein Isoforms (Isoforms)IBA 01/2022 - 11/2017
2	ElectrolytesIBA 01/2022 - 11/2010
2	Dextrans (Dextran)FDA Link 01/2022 - 12/2021
2	ChitosanIBA 01/2021 - 11/2020
2	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2017
2	Dextran SulfateIBA 01/2021 - 08/2017
2	HydrogelsIBA 11/2020 - 07/2019
2	sodium bisulfide (NaHS)IBA 06/2020 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 12/2019 - 09/2008
2	CholesterolIBA 01/2019 - 01/2019
2	Immunoglobulin G (IgG)IBA 11/2018 - 01/2017
2	Sirtuin 1IBA 01/2018 - 11/2017
2	Monoclonal AntibodiesIBA 03/2017 - 01/2017
2	Conditioned Culture MediaIBA 01/2017 - 01/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016 - 12/2013
2	MicellesIBA 01/2016 - 09/2015
2	Dinitrochlorobenzene (DNCB)IBA 09/2015 - 07/2010
2	Gefitinib (Iressa)FDA Link 02/2009 - 11/2007
2	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2009 - 11/2007
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2009 - 11/2007
2	Irritants (Vesicants)IBA 10/2007 - 12/2005
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	Bortezomib (Velcade)FDA Link 06/2023
1	Aligeron (AS 2)IBA 01/2023
1	MethyltransferasesIBA 01/2023
1	AcyltransferasesIBA 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	thermozymocidin (myriocin)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023

Therapy/Procedure

16	Therapeutics 02/2024 - 11/2007
3	Drug Therapy (Chemotherapy) 12/2013 - 09/2008
2	Transplantation 12/2021 - 01/2020
2	Aftercare (After-Treatment) 01/2017 - 01/2014
1	Ambulatory Surgical Procedures (Outpatient Surgery) 03/2024
1	General Anesthesia 03/2024
1	Anesthesia 03/2024